187
Views
5
CrossRef citations to date
0
Altmetric
Research Articles

In silico evaluation of molecular interactions between macrocyclic inhibitors with the HCV NS3 protease. Docking and identification of antiviral pharmacophore site

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , , & show all
Pages 2260-2273 | Received 29 Sep 2020, Accepted 08 Jan 2022, Published online: 25 Jan 2022

References

  • Amirkhanov, V., Rauf, A., Ben Hadda, T., Ovchynnikov, V., Trush, V., Saleem, M., Raza, M., Rehman, T., Zgou, H., Shaheen, U., & Farghaly, T. (2019). Pharmacophores modeling in terms of prediction of theoretical physicochemical properties and verification by experimental correlations of carbacylamidophosphates (CAPh) and sulfanylamidophosphates (SAPh) tested as new carbonic anhydrase inhibitors. Mini-Reviews in Medicinal Chemistry, 19(12), 1015–1027. https://doi.org/10.2174/1389557519666190222172757
  • Bäck, M., Johansson, P.-O., Wångsell, F., Thorstensson, F., Kvarnström, I., Ayesa, S., Wähling, H., Pelcman, M., Jansson, K., Lindström, S., Wallberg, H., Classon, B., Rydergård, C., Vrang, L., Hamelink, E., Hallberg, A., Rosenquist, S., & Samuelsson, B. (2007). Novel potent macrocyclic inhibitors of the hepatitis C virus NS3 protease: Use of cyclopentane and cyclopentene P2-motifs. Bioorganic & Medicinal Chemistry, 15(22), 7184–7202. https://doi.org/10.1016/j.bmc.2007.07.027
  • Badshah, S. L., Ahmad, N., Ur Rehman, A., Khan, K., Ullah, A., Alsayari, A., Muhsinah, A. B., & N Mabkhot, Y. (2019). Molecular docking and simulation of Zika virus NS3 helicase. BMC Chemistry, 13(1), 67. https://doi.org/10.1186/s13065-019-0582-y
  • Bartenschlager, R. (2013). Hepatitis C virus: From molecular virology to antiviral therapy. Current Topics in Microbiology and Immunology, Springer-Verlag. https://doi.org/10.1007/978-3-642-27340-7.
  • Bechlem, K., Aissaoui, M., Belhani, B., Rachedi, K. O., Bouacida, S., Bahadi, R., Djouad, S. E., Mansour, R. B., Bouaziz, M., Almalki, F., Ben Hadda, T., & Berredjem, M. (2020). Synthesis, X-ray crystallographic study and molecular docking of new a-sulfamidophosphonates: POM analyses of their cytotoxic activity. Journal of Molecular Structure, 1210, 127990–127997. https://doi.org/10.1016/j.molstruc.2020.127990
  • Becke, A. D. (1993). Density-functional thermochemistry. III. The role of exact exchange. Journal of Chemical Physics, 98(7), 5648–5652. https://doi.org/10.1063/1.464913
  • Ben Hadda, T., Fergoug, T., Warad, I., Masand, V., & Sheikh, J. (2013a). POM as a quick bioinformatic platform to select flavonoids and their metabolites as potential and efficient HIV-1 integrase inhibitors. Research on Chemical Intermediates, 39(3), 1227–1244. https://doi.org/10.1007/s11164-012-0679-6
  • Ben Hadda, T., Kerbal, A., Bennani, B., Houari, G. A., Daoudi, M., Leite, A. C. L., Masand, V. H., Jawarkar, R. D., & Charrouf, Z. (2013b). Molecular drug design, synthesis and pharmacophore site identification of spiroheterocyclic compounds: Trypanosoma crusi inhibiting studies. Medicinal Chemistry Research, 22(1), 57–69. https://doi.org/10.1007/s00044-012-0010-5
  • Ben Hadda, T., Srivastava, S., Das, B., Zamora, H. S., Shaheen, U., Bader, A., & Naseer, M. M. (2014). POM analyses of antimicrobial activity of some 2,3-armed 4,5,6,7-tetrahydro-1-benzothiophenes: Favourable and unfavourable physico-chemical parameters in design of antibacterial and mycolytic agents. Medicinal Chemistry Research, 23(2), 995–1003. https://doi.org/10.1007/s00044-013-0707-0
  • Brintzinger, H. H., Prosenc, M. H., Schaper, F., Weeber, A., & Wieser, U. (1999). Alternative force field models for ansa-zirconocene complexes-vibrational and structural studies on Me2Si-bridged and tert-butyl-substituted representatives. Journal of Molecular Structure, 485–486, 409–419. https://doi.org/10.1016/S0022-2860(99)00184-2
  • Chohan, Z. H., Sumrra, S. H., Youssoufi, M. H., & Ben Hadda, T. (2010a). Design and synthesis of triazole Schiff bases and their oxovanadium(IV) complexes as antimicrobial agents. Journal of Coordination Chemistry, 63(22), 3981–3998. https://doi.org/10.1080/00958972.2010.523783
  • Chohan, Z. H., Sumrra, S. H., Youssoufi, M. H., & Hadda, T. B. (2010b). Metal based biologically active compounds: Design, synthesis, and antibacterial/antifungal/cytotoxic properties of triazole-derived Schiff bases and their oxovanadium(IV) complexes. European Journal of Medicinal Chemistry, 45(7), 2739–2747. https://doi.org/10.1016/j.ejmech.2010.02.053
  • Deppmeier, J. B., Driessen, A., Hehre, T. S., Hehre, W. J., Johnson, J. A., Klunzinger, P. E., & Pople, J. A. (2002). SPARTAN 02. Wave function Inc.
  • Francl, M. M., Pietro, W. J., Hehre, W. J., Binkley, J. S., Gordon, M. S., De Frees, D. J., & Pople, J. A. (1982). Self-consistent molecular orbital methods. XXIII. A polarization-type basis set for second-row elements. Journal of Chemical Physics, 77(7), 3654–3665. https://doi.org/10.1063/1.444267
  • Frisch, M. J., Trucks, G. W., Schlegel, H. B., Scuseria, G. E., Robb, M. A., Cheeseman, J. R., Scalmani, G., Barone, V., Petersson, G. A., Nakatsuji, H., Li, X., Caricato, M., Marenich, A., Bloino, J., Janesko, B. J., Gomperts, R., Mennucci, B., Hratchian, H. P., Ortiz, J. V., … Fox, J. D. (2009). Gaussian 09, Revision A.02. Gaussian 09 Inc.
  • Halfon, P., Locarnini, S. (2011). Hepatitis C virus resistance to protease inhibitors. Journal of Hepatology, 55(1), 192–206. https://doi.org/10.1016/j.jhep.2011.01.011
  • Huang, N., Kalyanaraman, C., Bernacki, K., & Jacobson, M. P. (2006). Molecular mechanics methods for predicting protein-ligand binding. Physical Chemistry Chemical Physics: PCCP, 8(44), 5166–5177. https://doi.org/10.1039/b608269f
  • Jogi, P. S., Meshram, J., Sheikh, J., & Ben Hadda, T. (2013). Synthesis, biopharmaceutical characterization, and antimicrobial study of novel azo dyes of 7-hydroxy-4-methylcoumarin. Medicinal Chemistry Research, 22(9), 4202–4210. https://doi.org/10.1007/s00044-012-0421-3
  • Jolliffe, I. T. (2002). Principal Component Analysis. 2nd Edition. Springer, New York.
  • Lafridi, H., Zaki, H., Zgou, H., & Bouachrine, M. (2018). 2D QSAR study of imidazothiazole-propenones derivatives as potential anticancer agents by DFT-QSAR models. Der Pharma Chemica, 10, 33–42.
  • Mabkhot, Y. N., Al-Showiman, S. S., Barakat, A., Soliman, S. M., Kheder, N. A., Alharbi, M. M., Asayari, A., Muhsinah, A. B., Ullah, A., & Badshah, S. L. (2019). Computational studies of 2-(4-oxo-3-phenylthiazolidin-2-ylidene)malononitrile. BMC Chemistry, 13(1), 25. https://doi.org/10.1186/s13065-019-0542-6
  • Mabkhot, Y. N., Arfan, M., Zgou, H., Genc, Z. K., Genc, M., Rauf, A., Bawazeer, S., & Ben Hadda, T. (2016). How to improve antifungal bioactivity: POM and DFT study of some chiral amides derivatives of diacetyl-Ltartaric acid and amines. Research on Chemical Intermediates, 42(12), 8055–8068. https://doi.org/10.1007/s11164-016-2578-8
  • McGivern, D. R., Masaki, T., Lovell, W., Hamlett, C., Saalau-Bethell, S., & Graham, B. (2015). Protease inhibitors block multiple functions of the NS3/4A protease-helicase during the hepatitis C virus life cycle. Journal of Virology, 89(10), 5362–5370. https://doi.org/10.1128/JVI.03188-14
  • Melnikova, I. (2011). Hepatitis C—pipeline update. Nat Rev Drug Discov, 10(2), 93–94. https://doi.org/10.1038/nrd3361
  • MOE. (2009). Molecular Operating Environment. Scientific Computing & Instrumentation. Vol. 2009.10 Re.
  • Morikawa, K., Lange, C. M., Gouttenoire, J., Meylan, E., Brass, V., Penin, F., & Moradpour, D. (2011). Nonstructural protein 3-4A: The Swiss army knife of hepatitis C virus. Journal of Viral Hepatitis, 18(5), 305–315. https://doi.org/10.1111/j.1365-2893.2011.01451.x
  • Nasir, A., Syed, L. B., Asharef, U. R., Akhtar, M., & Khalid, K. (2021). Structural insights into the Zika virus NS1 protein inhibition using a computational approach. Journal of Biomolecular Structure and Dynamics, 39(8), 3004–3011. https://doi.org/10.1080/07391102.2020.1759453
  • Parr, R. G., Pearson, R. G. (1983). Absolute hardness: Companion parameter to absolute electronegativity. Journal of the American Chemical Society, 105(26), 7512–7516. https://doi.org/10.1021/ja00364a005
  • Rachedi, K. O., Ouk, S. T., Bahadi, R., Bouzina, A., Djouad, S. E., Bechlem, K., Zerrouki, R., Ben Hadda, T., Almalki, F., & Berredjem, M. (2019). Synthesis, DFT and POM analyses of cytotoxicity activity of α-amidophosphonates derivatives: Identification of potential antiviral O,O-pharmacophore site. Journal of Molecular Structure, 1197, 196–203. https://doi.org/10.1016/j.molstruc.2019.07.053
  • Schiering, N., D’Arcy, A., Villard, F., Simic, O., Kamke, M., Monnet, G., Hassiepen, U., Svergun, D. I., Pulfer, R., Eder, J., Raman, P., & Bodendorf, U. (2011). A macrocyclic HCV NS3/4A protease inhibitor interacts with protease and helicase residues in the complex with its full-length target. Proceedings of the National Academy of Sciences of the United States of America, 108(52), 21052–21056. https://doi.org/10.1073/pnas.1110534108
  • Scola, P. M., Wang, A. X., Good, A. C., Sun, L.-Q., Combrink, K. D., Campbell, J. A., Chen, J., Tu, Y., Sin, N., Venables, B. L., Sit, S.-Y., Chen, Y., Cocuzza, A., Bilder, D. M., D’Andrea, S., Zheng, B., Hewawasam, P., Ding, M., Thuring, J., … McPhee, F. (2014). Discovery and early clinical evaluation of BMS-605339, a potent and orally efficacious tripeptidic acylsulfonamide NS3 protease inhibitor for the treatment of hepatitis C virus infection. Journal of Medicinal Chemistry, 57(5), 1708–1729. https://doi.org/10.1021/jm401840s
  • Senet, P. (1997). Chemical hardnesses of atoms and molecules from frontier orbitals. Chemical Physics Letters, 275(5–6), 527–532. https://doi.org/10.1016/S0009-2614(97)00799-9
  • Sheikh, J., Juneja, H., Ingle, V., Ali, P., & Ben Hadda, T. (2013). Synthesis and in vitro biology of Co(II), Ni(II), Cu(II) and Zinc(II) complexes of functionalized beta-diketone bearing energy buried potential antibacterial and antiviral O,O pharmacophore sites. Journal of Saudi Chemical Society, 17(3), 269–276. https://doi.org/10.1016/j.jscs.2011.04.004
  • Sheikh, J., Parvez, A., Juneja, H., Ingle, V., Chohan, Z., Youssoufi, M., & Ben Hadda, T. (2011). Synthesis, biopharmaceutical characterization, antimicrobial and antioxidant activities of 1-(4'-O-β-D-glucopyranosyloxy-2'-hydroxyphenyl)-3-aryl-propane-1,3-diones. European Journal of Medicinal Chemistry, 46 (4), 1390–1399. https://doi.org/10.1016/j.ejmech.2011.01.068
  • Sorrell, M. F., Belongia, E. A., Costa, J., Gareen, I., Grem, J. L., Inadomi, J. M., Kern, E. R., McHugh, J. A., Petersen, G. M., Rein, M. F., Strader, D. B., & Trotter, H. T. (2009). National Institutes of Health consensus development conference statement: Management of hepatitis B. Annals of Internal Medicine, 150(2), 104–110. https://doi.org/10.1002/hep.22946.
  • Stauber, R. E., Kessler, H. H. (2008). Drugs in development for hepatitis C. Drugs, 68(10), 1347–1359. https://doi.org/10.2165/00003495-200868100-00002.
  • Tun, W., Vu, L., Adebajo, S. B., Abiodun, L., Sheehy, M., Karlyn, A., Njab, J., Ahonsi, B., Issa, K. B., & Idogho, O. (2013). Population-based prevalence of hepatitis B and C virus, HIV, syphilis, gonorrhoea and chlamydia in male injection drug users in Lagos, Nigeria. International Journal of STD & AIDS, 24(8), 619–625. https://doi.org/10.1177/0956462413477553
  • Wadood, A., Riaz, M., Uddin, R., & Ul-Haq, Z. (2014). In silico identification and evaluation of leads for the simultaneous inhibition of protease and helicase activities of HCV NS3/4A protease using complex based pharmacophore mapping and virtual screening. PLoS One, 9(2), e89109. https://doi.org/10.1371/journal.pone.0089109
  • Wei, D. Q., Ma, Y., Cho, W. C., Xu, Q., & Zhou, F. (2017). Translational bioinformatics and its application. Springer. https://doi.org/10.1007/978-94-024-1045-7.
  • XLSTAT Software. (2009). XLSTAT Company.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.